This inventor holds 2 USPTO granted patents. Top assignee: Nanyang Technological University. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Xianfeng Huang: Innovator in Beta-Lactamase Detection
Introduction
Xianfeng Huang is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, particularly in the detection of beta-lactamase activity. With a total of 2 patents, his work is paving the way for advancements in medical diagnostics.
Latest Patents
Huang's latest patents focus on methods and compounds for detecting beta-lactamase activity. The invention involves a method where a sample is contacted with a nanoparticulate tag. This tag comprises a metal or a combination of metals, or it may include a nanotube of a metal, boron nitride, and/or carbon. The respective metal is capable of forming various types of bonds with thio or seleno groups. The sample is then treated with a compound of specific general formulas. The beta-lactam moiety of the compound is cleaved by the beta-lactamase activity present in the sample. Consequently, a cleavage moiety is released and immobilized on the surface of the nanoparticulate tag. The presence of beta-lactamase activity is determined based on the immobilized cleavage moiety.
Career Highlights
Xianfeng Huang is affiliated with Nanyang Technological University, where he continues to engage in innovative research. His work has garnered attention for its potential applications in improving diagnostic methods in healthcare.
Collaborations
Huang collaborates with notable colleagues, including Bengang Xing and Tingting Jiang, who contribute to his research endeavors.
Conclusion
Xianfeng Huang's contributions to the detection of beta-lactamase activity highlight his role as an innovator in biotechnology. His patents reflect a commitment to advancing medical diagnostics and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
